EUDA — EUDA Health Holdings Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1847846 ·
Singapore
Last close
$18.00
Market Cap
$44.90M
52W High
$25.70
52W Low
$5.26
ADV30
235,054
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 1,716,562 | 345,145 | 5,984,084 |
| Dec 2024 | — | — | — | — | 1,697,810 | 237,605 | 4,269,878 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-52,873,188
Inventory
$2,844
Receivables
$334,202
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,820,264
EBITDA
$-2,236,242
Free Cash Flow
$-953,881
Enterprise Value
$34,860,560
Total Cash
$345,145
Total Debt
$2,401,371
Shares Out
2,494,325
Trailing EPS
$-1.47
Book Value
$-2.25
ROE
—
ROA
-89.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,820,264 | -2,440,512 | -2,772,762 | 1,716,562 | 5,984,084 | — | -2,426,535 |
| Dec 2024 | 4,011,005 | -2,579,571 | -15,357,156 | 1,697,810 | 4,269,878 | — | -2,034,727 |
| Dec 2023 | 3,706,458 | -3,961,054 | -10,039,481 | 1,310,508 | 8,792,444 | — | -2,917,895 |
| Dec 2022 | 3,764,295 | -5,880,612 | -24,884,122 | 25,629,040 | 29,136,071 | — | -1,526,828 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.60
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PIII | P3 Health Partners Inc. | $43.20M | $12.99 | — |
| MDXH | MDxHealth SA | $40.58M | $0.79 | — |
| CDIX | Cardiff Lexington Corp | $32.86M | $2.15 | — |
| DCGO | DocGo Inc. | $62.23M | $0.63 | — |
| EHSI | Elite Health Systems Inc. | $31.09M | $1.09 | — |
News headlines (Yahoo Finance, 1h cache)
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
2026-04-28 10:00 · Yahoo
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
2026-04-27 10:00 · Yahoo
EUDA Announces Reverse Stock Split of its Ordinary Shares
2026-03-19 09:30 · Yahoo
EUDA Health price target lowered to $2.75 from $6 at Greenridge
2026-03-10 14:00 · Yahoo
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
2026-03-04 14:10 · Yahoo
EUDA Health Announces Second Amendment to Streeterville Warrant Agreement
2026-01-15 13:59 · Yahoo
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
2026-01-13 12:49 · Yahoo
EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement
2026-01-07 11:00 · Yahoo
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
2025-12-30 12:00 · Yahoo
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
2025-12-29 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.